About AVT
Browse Articles
Customer Services

Browse Articles

Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.

Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 22 Issue 2 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.

Currently showing:   
Displaying 2102 results:

Workshop report

Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon

Catherine A Hankins, Sinata Koulla-Shiro, Peter Kilmarx, Guido Ferrari, Mauro Schechter, Coumba Touré Kane, François Venter, Charles AB Boucher, Anna-Laura Ross, Debrework Zewdie, Serge Paul Eholié, Elly Katabira

Antiviral Therapy 2017; 22:179-184

Short communication

Economic outcomes of influenza in hospitalized elderly with and without ICU admission

Yik-Kei Chan, Rity YK Wong, Margaret Ip, Nelson LS Lee, Joyce HS You

Antiviral Therapy 2017; 22:173-177

Short communication

Dolutegravir monotherapy as treatment de-escalation in HIV-infected adults with virological control: DoluMono cohort results

Celia Oldenbuettel, Eva Wolf, Ayla Ritter, Sebastian Noe, Silke Heldwein, Rita Pascucci, Carmen Wiese, Ariane Von Krosigk, Eva Jaegel-Guedes, Hans Jaeger, Annamaria Balogh, Christine Koegl, Christoph D Spinner

Antiviral Therapy 2017; 22:169-172

Short communication

Maraviroc ameliorates the increased adipose tissue macrophage recruitment induced by a high-fat diet in a mouse model of obesity

Patricia Pérez-Matute, José G Pichel, María Iñiguez, Emma Recio-Fernández, Laura Pérez-Martínez, Raquel Torrens, José Ramón Blanco, José Antonio Oteo

Antiviral Therapy 2017; 22:163-168

Original article

HIV infection rather than concurrent opportunistic infections drives most systemic procoagulant, vascular and damage responses – a prospective cohort study in central Africa

Saskia Janssen, Michaela AM Huson, Kara K Osbak, Elie-Gide Rossatanga, Abraham Alabi, René Lutter, Martin P Grobusch, Tom van der Poll

Antiviral Therapy 2017; 22:153-161

Original article

An open-label, randomized study of the impact on insulin sensitivity, lipid profile and vascular inflammation by treatment with lopinavir/ritonavir or raltegravir in HIV-negative male volunteers

Paul Randell, Akil Jackson, Ana Milinkovic, Marta Boffito, Graeme Moyle

Antiviral Therapy 2017; 22:145-151

Original article

Interchangeability between first-line generic antiretroviral products prequalified by WHO using adjusted indirect comparisons

Luther Gwaza, John Gordon, Jan Welink, Henrike Potthast, Hubert Leufkens, Matthias Stahl, Alfredo García-Arieta

Antiviral Therapy 2017; 22:135-144

Original article

Incidental findings on chest computed tomography are common and linked to inflammation in HIV-infected adults

Michelle S Park, Corrilynn O Hileman, Abdus Sattar, Robert Gilkeson, Grace A McComsey

Antiviral Therapy 2017; 22:127-133

Original article

Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s

Theodoros Kelesidis, Thuy Tien T Tran, Todd T Brown, Carlee Moser, Heather J Ribaudo, Michael P Dube, Otto O Yang, Grace A McComsey, James H Stein, Judith S Currier

Antiviral Therapy 2017; 22:113-126

Original article

HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia

Yeshambel Belyhun, Melanie Maier, Uwe Gerd Liebert

Antiviral Therapy 2017; 22:97-111

Copyright © Nucleus Global 2017. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.